Endothelial cell protein C receptor and the risk of venous thrombosis

Haematologica

Volumn 93, Issue 6, 2008, Pages 812-816

  Gandrille, Sophie ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL CELL PROTEIN C RECEPTOR; RECEPTOR; RECEPTOR ANTIBODY;

ANTIBODY TITER; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; CARDIOVASCULAR RISK; EDITORIAL; ENDOTHELIUM CELL; HAPLOTYPE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; RECEPTOR BINDING; VEIN THROMBOSIS;

ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; BLOOD COAGULATION FACTORS; CELL MEMBRANE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HAPLOTYPES; HUMANS; KINETICS; MALE; MODELS, BIOLOGICAL; RECEPTORS, CELL SURFACE; RISK; RNA, MESSENGER; VENOUS THROMBOSIS;

EID: 44949164413     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13243     Document Type: Editorial

References (39)

1. Esmon CT. The protein C pathway. Chest 2003;124:36S-32S.
2. Esmon CT. Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004;25:536-42.
3. Van de Wouwer M, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system. Integrated to regulated coagulation and inflammation. Arterioscler Thromb Vasc Biol 2004;24:1374-83.
4. Fukudome K, Esmon CT. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994;269:26486-91.
5. Laszik Z, Mitro A, Taylor FB Jr, Ferrell G, Esmon CT. Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation 1997;96:3633-40.
6. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 1996;93:10212-6.
7. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982;257:859-64.
8. Taylor FB Jr, Peer GT, Lockhart MS, Ferrell G, Esmon CT. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 2001;15;97:1685-8.
9. Gu JM, Crawley JT, Ferrell G, Zhang F, Li W, Esmon NL, et al. Disruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. J Biol Chem 2002;277:43335-43.
10. Esmon CT. The endothelial protein C receptor. Curr Opin Hematol 2006;13:382-5.
11. Simmonds RE, Lane DA. Structural and functional implications of the intron/exon organization of the human endothelial cell protein C/activated protein C receptor (EPCR) gene: comparison with the structure of CD1/major histocompatibility complex alpha1 and alpha2 domains. Blood 1999;94:632-41.
12. Ghosh S, Pendurthi UR, Steinoe A, Esmon CT, Rao LV. Endothelial cell protein C receptor acts as a cellular receptor for factor VIIa on endothelium. J Biol Chem 2007;282:11849-57.
13. López-Sagaseta J, Montes R, Puy C, Díez N, Fukudome K, Hermida J. Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity. J Thromb Haemost 2007; 5:1817-24.
14. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem 2001;276:11199-203.
15. Ludeman MJ, Kataoka H, Srinivasan Y, Esmon NL, Esmon CT, Coughlin SR. PAR1 cleavage and signaling in response to activated protein C and thrombin. J Biol Chem 2005;280:13122-8.
16. Liaw PC, Neuenschwander PF, Smirnov MD, Esmon CT. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem 2000;275:5447-52.
17. Kurosawa S, Esmon CT, Stearns-Kurosawa DJ. The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. J Immunol 2000;165:4697-703.
18. Biguzzi E, Merati G, Liaw PC, Bucciarelli P, Oganesyan N, Qu D, et al. A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost 2001;86:945-8.
19. Stearns-Kurosawa DJ, Burgin C, Parker D, Comp P, Kurosawa S. Bimodal distribution of soluble endothelial protein C receptor levels in healthy populations. Thromb Haemost 2003;1:855-6.
20. Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, Gandrille S. A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 2004;103:1311-8.
21. Medina P, Navarro S, Estellés A, Vayá A, Woodhams B, Mira Y, et al. Contribution of polymorphisms in the endothelial protein C receptor gene to soluble endothelial protein C receptor and circulating activated protein C levels, and thrombotic risk. Thromb Haemost 2004;91:905-11.
22. Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, de Visser MC, Bertina RM. Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost 2004;2:1305-10.
23. Qu D, Wang Y, Song Y, Esmon NL, Esmon CT. The Ser219->Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J Thromb Haemost 2006; 4:229-35.
24. Saposnik B, Lesteven E, Lokajczyk A, Esmon CT, Aiach M, Gandrille S. Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma. Blood 2008;111:3442-51.
25. Simioni P, Morboeuf O, Tognin G, Gavasso S, Tormene D, Woodhams B, et al. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants. Thromb Res 2006;117:523-8.
26. Navarro S, Medina P, Mira Y, Estellés A, Villa P, Ferrando F, et al. Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation. Haematologica 2008;93:885-91.
27. Medina P, Navarro S, Estellés A, Vayá A, Bertina RM, España F. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden. Thromb Haemost 2005;94:389-94.
28. Ireland H, Konstantoulas CJ, Cooper JA, Hawe E, Humphries SE, Mather H, et al. EPCR Ser219Gly: elevated sEPCR, prothrombin F1+2, risk for coronary heart disease, and increased sEPCR shedding in vitro. Atherosclerosis, 2005;183:283-92.
29. Sesin CA, Yin X, Esmon CT, Buyon JP, Clancy RM. Shedding of endothelial protein C receptor contributes to vasculopathy and renal injury in lupus: in vivo and in vitro evidence. Kidney Int 2005;68:110-20.
30. Kurosawa S, Stearns-Kurosawa D, Carson CW, D'Angelo A, Della Valle P, Esmon CT. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. Blood 1998;91:725-7.
31. Faust SN, Levin M, Harrison OB, Goldin RD, Lockhart MS, Kondaveeti S, Laszik Z, Esmon CT, Heyderman RS. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. N Engl J Med 2001;345:408-16.
32. Tsuneyoshi N, Fukudome K, Horiguchi SI, Ye X, Matsuzaki M, Toi M, et al. Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines. Thromb Haemost 2001;85:356-61.
33. Scheffer GL, Flens MJ, Hageman S, Izquierdo MA, Shoemaker RH, Scheper RJ. Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells. Eur J Cancer 2002;38:1535-42.
34. Beaulieu LM, Church FC. Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1. Exp Cell Res 2007;313:677-87.
35. Molina E, Hermida J, lopez-Sagaseta , Puy C, Montes R. A truncated form of endothelial cell protein C receptor (EPCR) generated by alternative splicing is functionally similar to soluble EPCR. Haematologica 2008;93:878-84.
36. Hurtado V, Montes R, Gris JC, Bertolaccini ML, Alonso A, Martínez-González MA, et al. Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death. Blood 2004;104:1369-74.
37. Lavigne-Lissalde G, Cochery-Nouvellon E, Granier G, Quere I, Gris JC. Diffuse skin necrosis in a patient with an anti-endothelial cell protein C receptor autoantibody which blocks protein C activation. J Thromb Haemost 2005;3:413-5.
38. Lavigne-Lissalde G, Cochery-Nouvellon E, Mercier E, Marès P, Gris JC. High plasma levels of endothelial protein C receptor are associated with the risk of unexplained fetal death. J Thromb Haemost 2005;3:393-5.
39. Montes R, Hurtado V, Alonso A, Foco L, Zonzin P, Mannucci PM, et al. Autoantibodies against the endothelial receptor of protein C are associated with acute myocardial infarction in young women. J Thromb Haemost 2005;3:1454-8.